Chemcon Speciality Chemicals Ltd · NSE:CHEMCON

Chemcon Speciality Chemicals — Q3 FY24 Earnings Presentation

26 slides from Chemcon Speciality Chemicals's earnings presentation, Feb 10, 2024

  1. Slide 1: Regulation 30 cover letter to exchanges

    February 10, 2024 To, To, BSE Limited National Stock Exchange of India Limited Listing Compliance & Legal Regulatory Listing & Compliance Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex, Dalal Street, Mumbai - 400 001 Bandra East, Mumbai 400 051 Stock Code: 543233 Stock Symbol: CHEMC

  2. Slide 2: Chemcon Speciality Chemicals Limited Investor Presentation – February 2024

    Chemcon Speciality Chemicals Limited Investor Presentation – February 2024

  3. Slide 3: Safe Harbor

    Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Chemcon Speciality Chemicals Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe

  4. Slide 4: Q3 & 9M FY24 Performance Highlights

    Q3 & 9M FY24 Performance Highlights

  5. Slide 5: Q3 FY24 Performance Highlights

    Q3 FY24 Performance Highlights “Quarterly performance continued to face headwinds due to moderate demand and lower realization of our key products in organic chemical. Organic Chemicals like HMDS & CMIC continue to witness pressure from pharmaceutical manufacturers and still seems soft as major cust

  6. Slide 6: Financial Highlights

    Financial Highlights Total Revenue (Rs. Cr) EBITDA (Rs. Cr) PAT (Rs. Cr) 76.5 75.2 13.5 11.4 53.0 8.3 6.3 5.9 4.4 Q3 FY23 Q2 FY24 Q3 FY24 Q3 FY23 Q2 FY24 Q3 FY24 Q3 FY23 Q2 FY24 Q3 FY24 Geographic-Wise (%) Business-wise (%) Sales Volume (MT) 100% 100% 100% 3,377 3% 2% 3% 2,978 Others 2,851 100% 100%

  7. Slide 7: Financial Highlights

    Financial Highlights Total Revenue (Rs. Cr) EBITDA (Rs. Cr) PAT (Rs. Cr) 223.8 56.6 44.6 207.5 22.5 16.3 9M FY23 9M FY24 9M FY23 9M FY24 9M FY23 9M FY24 Geographic-Wise (%) Business-wise (%) Sales Volume (MT) 100% 100% 8,694 100% 100% 3% 3% 7,754 Others 37% Inorganic Chemicals 32% 43% Export 58% 5,3

  8. Slide 8: Profit & Loss Statement

    Profit & Loss Statement Particulars (Rs. Crs) Q3 FY24 Q3 FY23 Y-o-Y 9M FY24 9M FY23 Y-o-Y Revenue from Operations 53.0 76.5 -30.7% 207.5 223.8 -7.3% Cost of Goods Sold 34.3 49.0 147.6 122.2 Employee Cost 4.2 4.9 13.2 15.5 Other Expenses 8.2 9.1 24.2 29.5 EBITDA 6.3 13.5 -53.0% 22.5 56.6 -60.3% EBITD

  9. Slide 9: Company Overview

    Company Overview

  10. Slide 10: Company Snapshot

    Company Snapshot Incorporated in 1988 Only Manufacturer of HMDS in India Manufacturer of Speciality Chemicals 3rd Largest Manufacturer of HMDS Worldwide An ISO 9001:2015 and ISO 14001:2015 Certified Company Largest Manufacturer of CMIC worldwide Business Verticals: Organic Chemicals and Inorganic Ch

  11. Slide 11: Evolution

    Evolution FY89 FY95-98 FY01-03 FY05 FY14 FY15-16 » Company was » First sale of few » Commenced HMDS » First export shipment of » First sale of CMIC » First sale of Calcium incorporated as chemical products Business in 2001 HMDS Bromide (Solution) Gujarat Quinone • Pyridine Private Limited Hydrobromi

  12. Slide 12: Global Market Presence

    Global Market Presence Global Presence Key Countries » United States of » Japan America » United Arab FY23 Export Contribution*: » Italy Emirates ~59% » South Korea » Germany » Russia » Spain » People’s Republic of » Thailand China » Malaysia Over Two Decades of • Manufacturing Well Equipped to Seiz

  13. Slide 13: Entry Barriers

    Entry Barriers Complex Chemistry Stringent Impurity Measure » The involvement of complex chemistry in » Our processes and products are subject to, and the manufacture of the Products, which is measured against, high quality standards and difficult to commercialize on a large scale stringent impurity

  14. Slide 14: Key Long-Term Relationships

    Key Long-Term Relationships Organic Chemicals Inorganic Chemicals Shree Radha CC Gran Limited Overseas Liability Company Longstanding New Product New Customer Strong Base Clients Development Reach Major customers Leading to increase Few customers age Well equipped to Top 5 customers Top 10 customers

  15. Slide 15: Moving up the Value Chain

    Moving up the Value Chain Commenced Bromobenzene business in FY15 Revenue FY23 Revenue 2023 Business Rs 303 Crs Rs 64 Crs Commenced Bromide business in 2015 Organic Rs 46 Crs Rs 185 Crs Chemicals Commenced CMIC business in 2014 Inorganic Rs 13 Crs Rs 107 Crs Chemicals Commenced HMDS business in 2001

  16. Slide 16: Key Certifications

    Key Certifications Key Certificates R&D Environment In-house laboratory to test Complying All Environment Laws » Raw materials procured » The Environment (Protection) Act, 1986 » New Products & Innovation » Water Prevention and Control of Pollution Act » Final products testing at the various stages

  17. Slide 17: Product Overview

    Product Overview

  18. Slide 18: Product Portfolio

    Product Portfolio Organic Chemicals Inorganic Chemicals HMDS CMIC Bromobenzene Bromides HMDS ▪ HMDS, an organosilicon ▪ CMIC is an antiviral drug ▪ Bromobenzene, is a clear, ▪ Oilwell Completion Chemicals compound, is a reagent and a intermediate product, which is a colourless or pale-yellow liquid.

  19. Slide 19: Manufacturing Facilities

    Manufacturing Facilities Located at Manjusar near Installed Capacity Vadodara, Gujarat Sr No Product categories Key Products (MTPA) 9 Operational Plants 1 HMDS, CMIC, Bromobenzene and other ancillary products 10,800 2 Proposed Expansion Plant 2 Organic Chemicals Proposed P-10 Capacity Q4FY24e under

  20. Slide 20: Located at Manjusar near Vadodara, Gujarat

    Located at Manjusar near Vadodara, Gujarat 19

  21. Slide 21: Growth Drivers

    Growth Drivers Capacity Expansion Import Substitution » We plan to add additional manufacturing capacity P10 unit by end of FY24 and P11 » Aims to capitalize on the potential growth of Organic Chemicals in India and to unit by FY25. These additional capacity will manufacture organic chemicals substi

  22. Slide 22: Way Forward

    Way Forward Exploring Moderate Growth in Healthy Growth in Opportunities in Organic Chemicals Inorganic Chemicals New Products Leading to Long Term Sustainable Growth New Products, New Clients, New Applications, New Opportunities 21

  23. Slide 23: Financial Highlights

    Financial Highlights

  24. Slide 24: Financial Trends

    Financial Trends Total Revenue (Rs. Cr) EBITDA (Rs. Cr) PAT (Rs. Cr) 303.3 302.9 81.1 81.6 62.8 262.1 257.1 70.3 70.7 56.4 55.1 243.5 66.1 48.9 43.0 FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23 Geographic-Wise (%) Business-wise (%) Sales Volume (MT) Others Inorganic Org

  25. Slide 25: Key Ratios

    Key Ratios Fixed Asset Net Debt/ equity (x) Turnover(x) 0.35 7.7 0.31 5.5 0.15 3.7 3.2 0.09 2.1 0.01 FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23 ROCE (%) ROE (%) 49% 45% 35% 34% 21% 19% 16% 15% 15% 12% FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23 24

  26. Slide 26: Thank You

    Thank You Chemcon Speciality Chemicals Ltd. CIN – L24231GJ1988PLC011652 Mr. Rajesh Gandhi - CFO Email – rajesh@cscpl.com www.cscpl.com Strategic Growth Advisors Pvt. Ltd. CIN - U74140MH2010PTC204285 Mr. Shrikant Sangani / Ms. Shaily Patwa Email - shrikant.sangani@sgapl.net/ shaily.p@sgapl.net +91 96

Chemcon Speciality Chemicals — Q3 FY24 Earnings Presentation on 6ix